NPC Healthbiz Weekly

NPC Healthbiz Weekly

Home
Podcast
Archive
About
S14 E03 Sobi Canada’s Bob McLay: Life Science Leadership in Rare Disease
Bob McLay, General Manager of Sobi Canada, gives insights into stewarding rare drug therapies, KOL advocacy and the future of preventative medicine.
 • 
Jeremy Visser
31:32
Tech-enabled pharmacies are reshaping care. Here’s how to approach the trend
AI-driven telepharmacy, automated workflows, and hybrid ‘tech + touch’ models are cutting processing times and boosting adherence (Issue #336, 1,220…
 • 
Cristela Tello Ruiz
S14 E02 Developing Disease Modifying Therapeutics for ALS at Neuropeutics
Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie…
 • 
Jeremy Visser
25:00
AI regulation tsunami hits pharma: FDA draft guidance and EU AI Act demand new compliance strategies
As regulatory authorities roll out strict AI oversight frameworks, pharma companies face mounting pressure to embed transparency, validation and bias…
 • 
Cristela Tello Ruiz

June 2025

mRNA vaccines expand beyond Covid-19 into oncology and infectious diseases
Clinical research surges as mRNA technology shifts toward cancer treatment, rare diseases, and global health threats (Issue #335, 1000 words, 5 minutes)
 • 
Cristela Tello Ruiz
From faster timelines to smarter clinical trials — How AI is revolutionizing drug discovery
The value lies in enhancing patient recruitment, optimizing study design, and enabling real-time adjustments (Issue #334, 1,300 words, 6.5 minutes)
 • 
Cristela Tello Ruiz
Tech is transforming the pharma industry, speeding drug discovery and personalizing medicine
It's all about AI, and much more. Get ready for the next waves of disruptive technologies (Issue #333, 1,371 words, 6.5 minutes)
 • 
Cristela Tello Ruiz
Revolutionizing chronic care: The next frontier in precision medicine
From Alzheimer’s breakthroughs to diabetes and cardiovascular innovations, cutting-edge therapies are reshaping treatment paradigms—and the…
 • 
Cristela Tello Ruiz

May 2025

First AbbVie Biotech Innovators Award goes to Neuropeutics
Startup focused on neurodegenerative disease research to receive support from the SpinUp incubator at the University of Toronto Mississauga (Issue #332…
 • 
Cristela Tello Ruiz
Feds looking for more transparency in drug pricing
Proposed pricing reforms put emphasis on clinical effectiveness and real-world outcomes (Issue #331, 1,200 words, 6 minutes)
 • 
Cristela Tello Ruiz
Pharma regulation 2025: Digital transformation, AI, and global harmonization reshape the compliance landscape
Regulatory agencies worldwide are embracing cloud technologies and AI to streamline approvals, strengthen data integrity, and accelerate innovation…
 • 
Cristela Tello Ruiz
Pharma M&A: What's the global landscape for 2025?
Technological innovation and favourable market conditions drive a new wave of high-stakes mergers and acquisitions in the life sciences (Issue #329…
 • 
Cristela Tello Ruiz
© 2025 Chronicle Information Resources Ltd.
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture